Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Stem cell therapies show promise for treating hair loss, but more research is needed to understand their safety and effectiveness.

Chemotherapy caused a woman's permanent hair loss and early menopause.

The hair growth serum Trichosera® was effective in increasing hair regrowth and density and reducing hair fall without significant side effects.

A child with a rare scalp condition regrew hair after treatment.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Some breast cancer chemotherapy can cause permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

A woman's chronic headaches and hair loss were cured by treating her syphilis.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Timolol eye-drops can cause hair loss.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A new mutation in the CDH3 gene causes hair loss and vision problems in a young girl.

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

Hair loss can be a symptom of syphilis.

A girl's hair loss was found to be caused by both a hair-pulling disorder and another hair loss condition.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

A 22-year-old homosexual man was diagnosed with secondary syphilis, genital warts, and HIV, highlighting the high STI risk in men who have sex with men.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.